Brittney Cotta, MD

Urologic Oncologist @MDAndersonnews •by way of @UCSD_Urology @UrologyMSK @UMichUrology

[European Urology Oncology @EurUrolOncol]

🎆Editor's Choice!

📝"Current risk stratification for non-clear cell renal cell carcinoma (nccRCC) is largely derived from clear cell RCC (ccRCC) data. We evaluated recurrence patterns following surgery for nccRCC and compared the prognostic performances of various international guidelines."

🩺Beyond Clear Cell: Rethinking Postoperative Surveillance for Non-clear Cell Renal Cell Carcinoma Subtypes by Arighno Das et al

🔎Read the full article on our website: https://t.co/JiZeyejWPc

❗Disclaimer: The clinical relevance on this post was summarised for social media - refer to the full clarification on the article.

🙌We thank the authors for trusting EUO to publish your work!

@ArighnoD
@BCottaMD
@SurenaMatinMD

@uroweb
@mroupret
@GPloussard
@jteoh_hk
@Ric_Campi
@CaPsurvivorship
@LauraMarandino
@RenuEapen
@Ecastromarcos
@OncoAlert
@Sciencedirect

[KidneyCAN @kidneycan]

Today, on #InternationalWomensDay, we recognize the women affected by #KidneyCancer, as patients, caregivers, researchers, and advocates.

While kidney cancer is more common in men, thousands of women are diagnosed each year, and outcomes can vary based on stage, access to care, and participation in clinical research. Women remain underrepresented in some areas of research, making awareness and inclusion especially important.

#AcceleratingCures #KidneyCancerAwarenessMonth

[Nisha Patel, MD MS, Dipl of ABOM, CCMS @DrPlantel]

The phrase “root cause of disease” has basically become wellness influencer code for: “I have no idea what I’m talking about, but here’s my discount code anyway.”
#DoctorsSuck2026

[Brittney Cotta, MD @BCottaMD]

@samsimsal @monda_steven @wandering_gu @drmehrarohit @gpalapa2

[Brittney Cotta, MD @BCottaMD]

Happy to share our newly published study on the tumor immune microenvironment in clear cell renal cell carcinoma.

https://t.co/7JjBF7NcEO

[Brittney Cotta, MD @BCottaMD]

Using paired treatment-naïve primary tumors and asynchronous metastases, we found higher Treg infiltration in primary tumors and site-specific pathway differences across metastases.

Grateful to my co-authors, collaborators, and mentors for their support and contributions.

[Current Oncology @CurrentOncology]

📢 Call for Papers!
🎊 Special Issue: Advances in Novel Biomarkers for Kidney Cancer
🎓 Guest Editor: Dr. Brittney H. Cotta
⏰ Submission Deadline: 15 June 2026
🔍 Discover More: https://t.co/ZxxAUmvwv7
✨ #Biomarkers #KidneyCancer #CallForPapers

[UroToday.com @urotoday]

Techniques for surgical treatment of #RCC with morbidly obese patients. Presentation by @BCottaMD @MDAndersonNews. #SCSAUA25 written coverage by @zklaassen_md @GACancerCenter > https://t.co/KvboeCuF0q #SCS2025 @SCSAUA

[Brian F. Chapin @ChapinMD]

And welcome to out @UroOnc @MDAndersonNews class of 2027!
#oncsurgery #endcancer

[Brian F. Chapin @ChapinMD]

Congratulations to our fellowship class
Of 2024! We are proud of your accomplishments and wish you luck as you begin your faculty appointments.
#oncsurgery @MDAndersonNews

[Simpa Salami @samsimsal]

1/6: Congrats to our #team on the recent @JCOPO_ASCO publication! We've developed a novel 15-gene prognostic signature (15G) for clear cell renal cell carcinoma (ccRCC) to facilitate risk stratification and management. #KidneyCancer #OncologyResearch

[Brian F. Chapin @ChapinMD]

@MDAndersonNews will be hosting @UroOnc Fellowship interviews on three dates.

We are having 2 planned in person dates and 1 virtual date.

Reception night prior for all 3

In-Person: Mar 4 and April 22
Virtual: Mar 27

Explore your opportunities
#oncsurgery

[Brittney Cotta, MD @BCottaMD]

@SUO_YUO @samsimsal @AmerUrological @UMichUrology @UroOnc Wow!! Congratulations!!

[Brian F. Chapin @ChapinMD]

Please join us for an open house for applicants to the @UroOnc @MDAndersonNews fellowship program November 16th, 7pm CST

Hear an overview of our program + meet faculty and fellows

Pre-registration required. Please DM your email or email separately for the link
#oncsurgery

[Brittney Cotta, MD @BCottaMD]

@AdityaBagrodia @_backtable @AaronFrittsMD @SDhandMD @JacobFlemingMD @bahetimd @beckcj @JMichaelBarraza @ucsd_ir @UTSW_VIR @SIRspecialists @UCSD_Urology @cjkane10 Love it. In San Diego I also saw a Tesla with “0 Flatus”

[European Urology @EUplatinum]

Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma

https://t.co/agh9c5YhxT

@BCottaMD @DrChoueiri @GhataliaPooja @drmehrarohit @wandering_gu @gpalapa2 @KidneyCancerDoc @DrVaishampayan @arihakimi @samsimsal

#Medtwitter #UroSoMe

[Dr. Longissimus @DrLongissimus]

In honor of the new residency application cycle, I asked chatGPT to write a CT abdomen pelvis report using Gen Z lingo

[Brian F. Chapin @ChapinMD]

@MDAndersonNews Dept of Urology spin class @cyclebar West U

Great wellness activity focusing on our @UroOnc fellows @SUO_YUO and @UTHUrology residents

Recruiting now for the entering class of 2025!

#oncsurgery @ppisters @sgswisher

[Brittney Cotta, MD @BCottaMD]

@ClareZimMD @Target At least 30 large muslin burp cloths.

[Brittney Cotta, MD @BCottaMD]

@CaseySeidemanMD Train at a residency program with high volume onc. Again, another training quality issue. I agree with you that there may be a need for adv surgical training in onc due to complexity depending on practice environment. Something we need to think about.